Skip to Main Content

Advertisement

Skip Nav Destination

Abstract B201: A phase 1 dose-finding study of X4P-001 (an oral CXCR4 inhibitor) and axitinib in patients with advanced renal cell carcinoma (RCC)

Mol Cancer Ther (2018) 17 (1_Supplement): B201.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Yasir Khan
  • Timothy D. Slattery
  • Lisa M. Pickering
Cancers (2020) 12 (12): 3750.
  • David C. Dale
  • Frank Firkin
  • Audrey Anna Bolyard
  • Merideth Kelley
  • Vahagn Makaryan
  • Kenneth J. Gorelick
  • Tarek Ebrahim
  • Varun Garg
  • Weihua Tang
  • Honghua Jiang
  • Renato Skerlj
  • Sarah Beaussant Cohen
Blood (2020) 136 (26): 2994.
  • Priya Narvekar
  • Priyanka Bhatt
  • Gulimirerouzi Fnu
  • Vijaykumar Sutariya
ASSAY and Drug Development Technologies (2019) 17 (4): 167.
  • Ritesh R. Kotecha
  • Robert J. Motzer
  • Martin H. Voss
Nature Reviews Clinical Oncology (2019) 16 (10): 621.
  • Lynda Vuong
  • Ritesh R. Kotecha
  • Martin H. Voss
  • A. Ari Hakimi
Cancer Discovery (2019) 9 (10): 1349.
Close Modal

or Create an Account

Close Modal
Close Modal